Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

This study has been completed.

Sponsor:

Information provided by:

PowderMed

ClinicalTrials.gov Identifier:

NCT00274300

First received: January 9, 2006

Last updated: January 25, 2007

Last verified: January 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	July 2005
Estimated Primary Completion Date:	No date given